Alembic Pharmaceuticals Ltd. (APLLTD) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 807696, "name": "Alembic Pharma", "stock_name": "Alembic Pharma", "full_name": "Alembic Pharmaceuticals Ltd.", "name_url": "stocks-analysis/alembic-pharma", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "771.50", "chg": -9.15, "chgp": "-1.17%", "dir": -1, "prev_price": "780.65", "mcapval": "15,369.00 Cr", "mcap": "Small Cap", "scripcode": 533573, "symbol": "APLLTD", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE901L01018", "curr_date": "Jun 25, 03:30 PM", "curr_time": "21:58 PM", "last_traded_at": "Jun 25, 03:30 PM IST", "bse_nse_vol": "26.48 k", "exc_status": "Active", "traded_date": "Jun 25, 2026", "traded_date_str": "2026 06 25", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alembic-pharma-807696-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Alembic Pharmaceuticals Ltd. is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/alembic-pharmaceuticals-ltd-is-rated-sell-4070174", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlembicPharmace_mojoScore_4070174.png", "date": "2026-06-24 10:11:01", "description": "Alembic Pharmaceuticals Ltd. is currently rated Sell by MarketsMOJO. This rating was last updated on 25 Nov 2025, reflecting a shift from the previous Hold status. However, the analysis and financial metrics presented here are based on the stock’s current position as of 24 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Alembic Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-4069632", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlembicPharmace_technicaldot_4069632.png", "date": "2026-06-24 08:03:45", "description": "Alembic Pharmaceuticals Ltd. has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a modest day decline of 0.55%, the stock’s weekly and monthly charts reveal contrasting signals that investors should carefully analyse amid broader market dynamics." }, { "title": "Alembic Pharmaceuticals Ltd. is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/alembic-pharmaceuticals-ltd-is-rated-sell-4050960", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlembicPharmace_mojoScore_4050960.png", "date": "2026-06-13 10:10:36", "description": "Alembic Pharmaceuticals Ltd. is rated Sell by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Alembic Pharmaceuticals Ltd. is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/alembic-pharmaceuticals-ltd-is-rated-sell-4030648", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlembicPharmace_mojoScore_4030648.png", "date": "2026-06-02 10:10:19", "description": "Alembic Pharmaceuticals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Alembic Pharmaceuticals Ltd. Technical Momentum Shifts Amid Bearish Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-technical-momentum-shifts-amid-bearish-signals-4029622", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlembicPharmace_technicaldot_4029622.png", "date": "2026-06-02 08:06:53", "description": "Alembic Pharmaceuticals Ltd. has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s recent downgrade from a Hold to a Sell rating reflects deteriorating price action and weakening market sentiment, underscored by a 2.21% decline in the latest trading session and a broader negative trend across weekly and monthly technical parameters." }, { "title": "Alembic Pharmaceuticals Declines 3.73%: Mixed Technical Signals Shape Weekly Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-declines-373-mixed-technical-signals-shape-weekly-performance-4008468", "imagepath": "", "date": "2026-05-23 15:05:44", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>18 May:</strong> Intraday low hit amid significant price pressure (Rs.723.95)</p>\n <p><strong>18 May:</strong> Technical momentum shifts to mildly bearish stance</p>\n <p><strong>19 May:</strong> Recovery attempt with 3.85% gain</p>\n <p><strong>22 May:</strong> Week closes at Rs.755.45, down 3.73%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.784.70</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.755.45</div><div class=\"stat..." }, { "title": "Alembic Pharmaceuticals Ltd. is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/alembic-pharmaceuticals-ltd-is-rated-sell-4004898", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlembicPharmace_mojoScore_4004898.png", "date": "2026-05-22 10:10:40", "description": "Alembic Pharmaceuticals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 22 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Alembic Pharmaceuticals Ltd. Hits Intraday Low Amid Price Pressure on 18 May 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-hits-intraday-low-amid-price-pressure-on-18-may-2026-3996449", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlembicPharmace_priceRelatedfactors_3996449.png", "date": "2026-05-18 09:51:02", "description": "Alembic Pharmaceuticals Ltd. experienced a notable decline today, hitting an intraday low of Rs 728, reflecting a sharp price pressure of -7.23% as the stock underperformed its sector and broader market indices amid a broadly bearish market environment." }, { "title": "Alembic Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-3996053", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlembicPharmace_technicaldot_3996053.png", "date": "2026-05-18 08:02:19", "description": "Alembic Pharmaceuticals Ltd. has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent price action and volume patterns suggest a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector." } ], "total": 5291, "sid": "807696", "stock_news_url": "https://www.marketsmojo.com/news/alembic-pharmaceuticals-807696" }, "announcements": [ { "details": "Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 26, 2019, titled \"Alembic Pharmaceuticals receives USFDA Final Approval for Silodosin Capsules, 4 mg and 8 mg.\".", "source": "NSE", "caption": "Alembic Pharmaceuticals Limited - Press Release", "datetime": "26-Nov-2019" }, { "details": "Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 22, 2019, titled \"Alembic Pharmaceuticals receives USFDA Approvals \".", "source": "NSE", "caption": "Alembic Pharmaceuticals Limited - Press Release", "datetime": "22-Nov-2019" }, { "details": "Alembic Pharmaceuticals Limited has informed the Exchange regarding Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 ( Listing Regulations, 2015 )", "source": "NSE", "caption": "Alembic Pharmaceuticals Limited - Other General Purpose", "datetime": "14-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Alembic Pharmaceuticals Ltd. has declared <strong>550%</strong> dividend, ex-date: 29 Jul 25", "dt": "2025-07-29", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

18 May: Intraday low hit amid significant price pressure (Rs.723.95)

18 May: Technical momentum shifts to mildly bearish stance

19 May: Recovery attempt with 3.85% gain

22 May: Week closes at Rs.755.45, down 3.73%

Read full news article

Alembic Pharmaceuticals Ltd. is Rated Sell

2026-05-22 10:10:40

Alembic Pharmaceuticals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 22 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Alembic Pharmaceuticals Ltd. Hits Intraday Low Amid Price Pressure on 18 May 2026

2026-05-18 09:51:02

Alembic Pharmaceuticals Ltd. experienced a notable decline today, hitting an intraday low of Rs 728, reflecting a sharp price pressure of -7.23% as the stock underperformed its sector and broader market indices amid a broadly bearish market environment.

Read full news article

Alembic Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Market Signals

2026-05-18 08:02:19

Alembic Pharmaceuticals Ltd. has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent price action and volume patterns suggest a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article